A TritonX-100-split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the Elderly.

Authors

B Lina
Mary A. Fletcher, Nova Southeastern UniversityFollow
M Valette
P Saliou
M Aymard

Publication Title

Biologicals : journal of the International Association of Biological Standardization

ISSN

1045-1056

Publication Date

6-1-2000

DOI

10.1006/biol.2000.0245

Volume

28

Issue

2

First Page

95

Last Page

103

Disciplines

Medical Specialties | Medicine and Health Sciences | Osteopathic Medicine and Osteopathy

NSUWorks Citation

Lina, B; Fletcher, Mary A.; Valette, M; Saliou, P; and Aymard, M, "A TritonX-100-split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the Elderly." (2000). Faculty Articles. 553.
https://nsuworks.nova.edu/hpd_com_faculty_articles/553